Disclosures for "Multiple Sclerosis in the Emergency Department: A Retrospective Case-control Study in a Large U.S. Center"
-
Mr. Satish has nothing to disclose.
-
Dr. Patel has nothing to disclose.
-
Ms. Mastick has nothing to disclose.
-
Miss Lee has nothing to disclose.
-
Ms. Hotan has received research support from Institute of High Performance Computing.
-
Andrew Siyoon Ham has nothing to disclose.
-
Miss Chen has nothing to disclose.
-
Ms. Tsai has nothing to disclose.
-
Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics (Amgen). Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics (Amgen). The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.